CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-18 | ORBIMED ADVISORS LLC Director | Sale | −1,724 | $59.24 | $102K | 0 |
| 2023-12-18 | ORBIMED ADVISORS LLC Director | Option exercise · Stock Options (Right to Buy) | −1,724 | 0 | ||
| 2023-12-18 | Ashiya Mona Director | Option exercise | +1,724 | $38.00 | $66K | 1,724 |
| 2023-12-18 | Ashiya Mona Director | Sale | −1,724 | $59.24 | $102K | 0 |
| 2023-12-18 | Ashiya Mona Director | Option exercise · Stock Options (Right to Buy) | −1,724 | 0 | ||
| 2023-12-14 | Ashiya Mona Director | Sale | −228,500 | $56.75 | $13.0M | 897,625 |
| 2023-12-14 | Ashiya Mona Director | Sale | −147,600 | $56.75 | $8.4M | 580,207 |
| 2023-12-14 | Ashiya Mona Director | Sale | −57,100 | $56.75 | $3.2M | 224,405 |
| 2023-12-14 | ORBIMED ADVISORS LLC Director | Sale | −228,500 | $56.75 | $13.0M | 897,625 |
| 2023-12-14 | ORBIMED ADVISORS LLC Director | Sale | −147,600 | $56.75 | $8.4M | 580,207 |
| 2023-12-14 | ORBIMED ADVISORS LLC Director | Sale | −57,100 | $56.75 | $3.2M | 224,405 |
| 2023-12-14 | Bitterman Kevin Director | Sale | −20,429 | $58.27 | $1.2M | 806,280 |
| 2023-12-14 | Bitterman Kevin Director | Sale | −120 | $59.74 | $7K | 806,160 |
| 2023-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −30,645 | $58.27 | $1.8M | 1,479,866 |
| 2023-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −20,429 | $58.27 | $1.2M | 806,280 |
| 2023-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −180 | $59.74 | $11K | 1,479,686 |
| 2023-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −120 | $59.74 | $7K | 806,160 |
| 2023-12-14 | ORBIMED ADVISORS LLC Director | Sale | −100 | $57.73 | $6K | 1,126,125 |
| 2023-12-14 | ORBIMED ADVISORS LLC Director | Sale | −100 | $57.73 | $6K | 727,807 |
| 2023-12-14 | Ashiya Mona Director | Sale | −100 | $57.73 | $6K | 1,126,125 |
Page 24 of 32 · 639 trades